giuseppe Minniti Profile
giuseppe Minniti

@gminniti2012

Followers
1K
Following
1K
Statuses
2K

radiation oncologist, neuro-oncologist, three lovely kids, working at Sapienza University of Rome πŸ™‚β€οΈβ€οΈ passion for science, family, friends and sport

Roma, Lazio
Joined February 2012
Don't wanna be here? Send us removal request.
@gminniti2012
giuseppe Minniti
2 days
another potential useful application of AI
@EditorNeuro
Editor - Neuro-Oncology Advances
3 days
Read about the recent study aiming to develop an automated algorithm to noninvasively distinguish #gliomas from other intracranial pathologies, preventing misdiagnosis and ensuring accurate analysis before further #glioma #assessment.
Tweet media one
0
0
2
@gminniti2012
giuseppe Minniti
2 days
Also for multifocal GBMs, the use of 1 cm CTV does not significantly affect oncological outcomes while reducing normal brain exposure. Reducing clinical target volume margins for multifocal glioblastoma: a multi-institutional analysis of patterns of …
1
7
29
@gminniti2012
giuseppe Minniti
6 days
The right imaging Is the Key to achieve optimal target delineation for brain SRS/SRT. Here neuroradiologists impress me with their visual art... So exciting to imagine how this can be useful for Radiation oncologists to preserve neurocognition in our patients
Tweet media one
Tweet media two
Tweet media three
0
0
5
@gminniti2012
giuseppe Minniti
6 days
Great question.. must read and think about that.. difficult to be Just in favor or against
@Nature
nature
7 days
Many scientists who have tried OpenAI's 'deep research' tool are impressed with its ability to write literature reviews or full review papers and even identify gaps in knowledge. But others are less enthusiastic.
0
0
0
@gminniti2012
giuseppe Minniti
6 days
Interesting data
@KaramLab
Sana Karam, MD, PhD
8 days
NEW from #KaramLab #Jake Gadwa @WUSTLDBBS @WUSTLImmuno TME dictates response to RT-IO: Tumor response vs progression using identical radiation-immunotherapy regimen is independent of cancer cell type but rather mediated by the TME & Tregs accumulation
Tweet media one
0
0
3
@gminniti2012
giuseppe Minniti
6 days
Last chance for @myESMO #TAT2025
@myESMO
ESMO - Eur. Oncology
28 days
Get the latest in early clinical trials at ESMO TAT 2025, from bispecific antibodies for IO, cell therapies in solid tumours (CART, NK cells, modified TCRs, TIL therapy) to MAPkinase pathway and associated targets (KRAS G12C, MAP2K4, combos). Register now!
Tweet media one
0
0
2
@gminniti2012
giuseppe Minniti
6 days
Interesting view.. must read
@NMNSymposium
Nuclear Medicine and Neurooncology (NMN)
7 days
Rethinking metastatic brain cancer as a CNS disease. @TheLancetOncol
0
1
3
@gminniti2012
giuseppe Minniti
6 days
3rd day in beautiful Naples for an Amazing IFNE workshop on skull base neuroendoscopy.. last check of my talk on combined SRS approaches for complex skull base tumors. Sharing own experience Is the Key to improve our knowledge. Thanks to my friend Prof Cavallo for the great time
Tweet media one
Tweet media two
0
0
0
@gminniti2012
giuseppe Minniti
8 days
Always keep moving
@NobelPrize
The Nobel Prize
8 days
β€œLife is like riding a bicycle. To keep your balance, you must keep moving.” Albert Einstein's life advice in a letter to his son Eduard on 5 February 1930. In the picture, Einstein is riding a bicycle in Santa Barbara, USA in 1933.
Tweet media one
0
0
2
@gminniti2012
giuseppe Minniti
8 days
0
0
0
@gminniti2012
giuseppe Minniti
11 days
The goal Is to control brain disease while preserving neurocognitive function in the se patients.. optimal timing of ADCs and SRS still and open question, as well best dose and fractionation
@JAMANetworkOpen
JAMA Network Open
13 days
Patients with HER2+ metastatic breast cancer face a high risk of death due to CNS involvement, and those with CNS-only disease had longer overall survival. @BouNassif_MD
Tweet media one
1
2
21
@gminniti2012
giuseppe Minniti
14 days
Radioligand therapy Is emerging as a promising treatment for meningiomas.. hopefully randomized trials Will be able to demonstrate this. An @EORTC trials Is starting soon to enroll patients with meningiomas in Europe
@ICOMeningioma
International Consortium on Meningiomas (ICOM)
15 days
Some of our #ICOM members recently published an article providing practice guideline/procedure standards for diagnostics and therapy (#theranostics) of #meningiomas using radiolabeled #somatostatin receptor ligands. Read more:
Tweet media one
1
3
24
@gminniti2012
giuseppe Minniti
19 days
A new standard of care in the se patients ...
@EANOassociation
EANO
20 days
A recent publication in ESMO Open covers the intracranial activity of T-DXd in HER2-positive breast cancer with brain metastases. Find out more πŸ‘‰#EANOessentials #NeuroOncology #BrainMetastases #BreastCancer
0
1
4
@gminniti2012
giuseppe Minniti
22 days
I am so proud to say that today four talented radiotherapy residents at @SapienzaRoma just took their final exams after 4 super challenging years. Congratulations to our new colleagues in radiotherapy. Good luck with a great future
Tweet media one
0
0
17
@gminniti2012
giuseppe Minniti
22 days
Great topic... definig optimal traget delineation strategy is essential to improve efficacy abd safety of radiation therapy. thank you to all authors Refining target delineation strategies for multifocal glioblastoma: a step towards personalized RT
1
2
13
@gminniti2012
giuseppe Minniti
22 days
Test yourself with a few questions on IDH- mut gliomas and Discovery what's new in the field @EANOassociation @NeuroOnc @ESTRO_RT @SapienzaRoma
@PeerView
PeerView
24 days
Explore the latest in biomarker testing and targeted therapies for IDH-mutant #gliomas, and learn how to integrate these advances into patient care. @BRAINTUMORDOC @theABTA
0
1
9
@gminniti2012
giuseppe Minniti
22 days
Interesting article.. have a look
@EANOassociation
EANO
24 days
An article discussing multiparametric MRI combined with machine learning is now available in @Nature. Learn more πŸ‘‰ #EANOessentials #NeuroOncology #glioma #MachineLearning #AI
0
0
0
@gminniti2012
giuseppe Minniti
29 days
Expanding the Role of PET has also improved the accuracy of target delineation for several brain tumors as glioma and meningiomas, and increase accuracy in diagnosis of radionecrosis @EANOassociation @ESTRO_RT @SapienzaRoma
@galldiks
Norbert Galldiks
30 days
Happy to share our latest on the value of multidisciplinary neuro-oncological tumor boards to increase the accuracy of FET PET for identifying brain tumor relapse. #AminAcidPet #Glioma #btsm #BrainMet @fz_juelich @UKKoeln
0
4
23
@gminniti2012
giuseppe Minniti
1 month
An interesting article highlighting the importance of neurosurgery in Neuro-Oncology Trials @EORTC @EANOassociation
@EANOassociation
EANO
1 month
A new article on #Neurosurgery can be found in European Journal of Cancer: Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group πŸ‘‰ #EANOessentials #btsm @EORTC
0
1
8
@gminniti2012
giuseppe Minniti
1 month
Four CNS guidelined on RT for GBM, Spine, IDH-mut gliomas, and reirradiation are most read (last 30 days) on @RO_GreenJournal . Improving the quality of our treatments means better outcome and QOL for our pts @ESTRO_RT @EANOassociation @MaxNiyazi @Mat_Guc @alongi_filippo
Tweet media one
1
20
67